PTI-2

PTI-2 (SGT-49) is an indole-based synthetic cannabinoid.^[1] It is one of few synthetic cannabinoids containing a thiazole group and is closely related to PTI-1. These compounds may be viewed as simplified analogues of indole-3-heterocycle compounds originally developed by Organon and subsequently further researched by Merck.^[2][3][4]

Legal status

• CA: Schedule II
• DE: NpSG (Industrial and scientific use only)
• UK: Class B

CAS Number

• 1400742-45-1

PubChem CID

• 124037377

ChemSpider

• 58827849

Quick facts Legal status, Identifiers ...

PTI-2

Legal status
Legal status	CA: Schedule II DE: NpSG (Industrial and scientific use only) UK: Class B
Identifiers
IUPAC name N-(2-methoxyethyl)-N-((2-(1-pentyl-1H-indol-3-yl)thiazol-4-yl)methyl)propan-2-amine
CAS Number	1400742-45-1
PubChem CID	124037377
ChemSpider	58827849
UNII	W0MO88040Q
Chemical and physical data
Formula	C23H33N3OS
Molar mass	399.60 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCCCCN1C=C(C2=CC=CC=C21)C3=NC(CN(C(C)C)CCOC)=CS3
InChI InChI=1S/C23H33N3OS/c1-5-6-9-12-26-16-21(20-10-7-8-11-22(20)26)23-24-19(17-28-23)15-25(18(2)3)13-14-27-4/h7-8,10-11,16-18H,5-6,9,12-15H2,1-4H3 Key:PSAKYYVEVVAWJL-UHFFFAOYSA-N

Close